Steffen Koschmieder Selected Research

Steffen Koschmieder Research Topics

Disease

38	Neoplasms (Cancer) 01/2022 - 03/2002
21	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2021 - 11/2003
19	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2020 - 04/2002
16	Leukemia 01/2020 - 04/2002
14	Primary Myelofibrosis (Myelosclerosis) 07/2022 - 01/2012
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2012 - 01/2009
4	Thrombosis (Thrombus) 08/2021 - 05/2016
4	Philadelphia Chromosome 01/2021 - 04/2006
4	Polycythemia Vera 01/2021 - 01/2018
4	COVID-19 01/2021 - 01/2020
4	Neoplasm Metastasis (Metastasis) 11/2020 - 01/2009
3	Anemia 03/2022 - 01/2018
3	Disease Progression 01/2021 - 01/2018
3	Fibrosis (Cirrhosis) 01/2021 - 01/2020
3	Systemic Mastocytosis 01/2021 - 01/2018
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2017 - 02/2007
3	Lung Neoplasms (Lung Cancer) 12/2011 - 03/2002
2	Thrombocytosis (Thrombocythemia) 04/2022 - 09/2021
2	Splenomegaly 04/2022 - 01/2018
2	Thrombocytopenia (Thrombopenia) 06/2021 - 01/2020
2	Hemorrhage 06/2021 - 02/2020
2	Pneumonia (Pneumonitis) 01/2021 - 11/2020
2	Infections 11/2020 - 06/2015
2	Inflammation (Inflammations) 08/2019 - 05/2013
2	Hematologic Diseases (Blood Diseases) 01/2018 - 02/2007
2	Diarrhea 01/2018 - 01/2013
2	Blast Crisis (Blast Phase) 09/2015 - 01/2013
2	Chromosome Aberrations (Chromosome Abnormalities) 05/2013 - 09/2007
2	Lymphoma (Lymphomas) 12/2011 - 03/2002
1	Leukocytosis (Pleocytosis) 04/2022
1	von Willebrand Diseases (von Willebrand's Disease) 09/2021
1	Hypertension (High Blood Pressure) 08/2021
1	Renal Insufficiency (Renal Failure) 06/2021
1	Liver Diseases (Liver Disease) 06/2021
1	Thrombophilia 06/2021
1	Essential Thrombocythemia 01/2021
1	Mast-Cell Leukemia (Leukemia, Mast Cell) 01/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021
1	Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 11/2020
1	Cytokine Release Syndrome 11/2020
1	Coronavirus Infections 11/2020

Drug/Important Bio-Agent (IBA)

11	Tyrosine Kinase InhibitorsIBA 10/2020 - 05/2013
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2005
9	ruxolitinibIBA 01/2021 - 01/2012
8	Phosphotransferases (Kinase)IBA 11/2020 - 04/2006
7	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 07/2009
5	CalreticulinIBA 01/2022 - 01/2016
5	Messenger RNA (mRNA)IBA 08/2021 - 01/2009
5	Pharmaceutical PreparationsIBA 01/2021 - 02/2015
5	Transcription Factors (Transcription Factor)IBA 11/2010 - 06/2005
4	Janus Kinase InhibitorsIBA 07/2022 - 01/2018
4	CytokinesIBA 11/2020 - 04/2002
4	Biomarkers (Surrogate Marker)IBA 05/2016 - 02/2007
4	Imatinib Mesylate (Gleevec)FDA Link 05/2013 - 04/2006
3	Biological ProductsIBA 01/2021 - 04/2006
3	bosutinibIBA 01/2018 - 01/2013
3	Histones (Histone)IBA 03/2012 - 04/2002
3	EphB6 ReceptorIBA 01/2012 - 07/2009
2	Thrombopoietin ReceptorsIBA 11/2021 - 01/2016
2	AnticoagulantsIBA 10/2021 - 02/2020
2	Interferon-alpha (Interferon Alfa)IBA 09/2021 - 01/2019
2	Lipocalin-2IBA 08/2021 - 11/2020
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021 - 02/2020
2	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 06/2003
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2020 - 01/2020
2	EnzymesIBA 11/2019 - 01/2019
2	Lysine (L-Lysine)FDA Link 01/2019 - 11/2010
2	ChromatinIBA 01/2018 - 11/2010
2	bcr-abl Fusion ProteinsIBA 05/2017 - 11/2003
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2017 - 01/2007
2	Rituximab (Mabthera)FDA Link 12/2011 - 04/2010
2	DNA (Deoxyribonucleic Acid)IBA 04/2010 - 02/2007
2	CCAAT-Enhancer-Binding Protein-alphaIBA 02/2009 - 06/2005
2	Immunoglobulins (Immunoglobulin)IBA 02/2007 - 06/2003
1	imetelstatIBA 07/2022
1	Telomerase (Telomerase Reverse Transcriptase)IBA 07/2022
1	Nonsense Codon (Nonsense Mutation)IBA 03/2022
1	Mutant Proteins (Protein, Mutant)IBA 01/2022
1	anagrelide (Agrylin)FDA LinkGeneric 09/2021
1	Uric Acid (Urate)IBA 08/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 08/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 06/2021
1	tasquinimodIBA 01/2021
1	VaccinesIBA 01/2021
1	AlarminsIBA 01/2021
1	AntigensIBA 01/2021
1	AndrogensIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Monatide (IMS 3015)IBA 01/2021
1	Protein Subunit VaccinesIBA 01/2021
1	Platelet Factor 4IBA 01/2021
1	nintedanibIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2020

Therapy/Procedure

24	Therapeutics 09/2021 - 02/2002
8	Drug Therapy (Chemotherapy) 04/2022 - 03/2002
4	Stem Cell Transplantation 08/2020 - 09/2012
1	Indwelling Catheters (Indwelling Catheter) 06/2021
1	Artificial Respiration (Mechanical Ventilation) 11/2020
1	Critical Care (Surgical Intensive Care) 11/2020